The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 04, 2018

Filed:

Feb. 18, 2015
Applicant:

Advaxis, Inc., Princeton, NJ (US);

Inventor:

Robert Petit, Newtown, PA (US);

Assignee:

Advaxis, Inc., Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/02 (2006.01); C12Q 1/6886 (2018.01); G01N 33/574 (2006.01); A61K 45/06 (2006.01); A61K 39/00 (2006.01); C07K 14/195 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0208 (2013.01); A61K 39/0011 (2013.01); A61K 45/06 (2013.01); C07K 14/195 (2013.01); C12Q 1/6886 (2013.01); G01N 33/574 (2013.01); A61K 2039/52 (2013.01); A61K 2039/53 (2013.01); C07K 2319/95 (2013.01); C12Q 2600/158 (2013.01);
Abstract

This invention provides methods and compositions for using evaluating biomarker expression in a disease and providing a multi-targeted-based immunotherapeutic approach against said disease. In a related aspect, the invention relates to a method of treating a disease in a subject, the method comprising the steps of: a. obtaining a biological sample from said subject; b. evaluating the expression of a predetermined number of biomarkers in said biological sample; c. administering to said subject a composition comprising a recombinantstrain, said strain comprising a nucleic acid sequence encoding at least one fusion protein, wherein said fusion protein comprises a biomarker identified in said biological sample, wherein said biomarker is associated with said disease, wherein said biomarker is fused to a PEST-containing polypeptide, and wherein each fusion protein within saidcomprises a different biomarker, thereby treating said disease in said subject.


Find Patent Forward Citations

Loading…